ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 2 filers reported holding ASLAN PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $30,590 | +33.0% | 84,972 | +123.1% | 0.00% | – |
| Q3 2022 | $23,000 | +27.8% | 38,083 | +5.7% | 0.00% | – |
| Q2 2022 | $18,000 | -43.8% | 36,013 | -0.8% | 0.00% | – |
| Q1 2022 | $32,000 | -8.6% | 36,289 | +16.8% | 0.00% | – |
| Q4 2021 | $35,000 | -79.7% | 31,068 | -67.8% | 0.00% | – |
| Q3 2021 | $172,000 | +60.7% | 96,629 | +198.4% | 0.00% | – |
| Q2 2021 | $107,000 | -0.9% | 32,379 | 0.0% | 0.00% | – |
| Q1 2021 | $108,000 | +107.7% | 32,379 | +14.0% | 0.00% | – |
| Q4 2020 | $52,000 | – | 28,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 568,182 | $1,068,181 | 0.12% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |